These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 9717750)

  • 41. Cytomegalovirus retinitis and viral resistance: ganciclovir resistance. CMV Retinitis and Viral Resistance Study Group.
    Jabs DA; Enger C; Dunn JP; Forman M
    J Infect Dis; 1998 Mar; 177(3):770-3. PubMed ID: 9498461
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Retinal detachment in cytomegalovirus retinitis: intravenous versus intravitreal therapy.
    Young S; McCluskey P; Minassian DC; Joblin P; Jones C; Coroneo MT; Lightman S
    Clin Exp Ophthalmol; 2003 Apr; 31(2):96-102. PubMed ID: 12648040
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cytomegalovirus retinitis in AIDS patients: a comparative study of intravenous and oral ganciclovir as maintenance therapy.
    Danner SA; Matheron S
    AIDS; 1996 Dec; 10 Suppl 4():S7-11. PubMed ID: 9110064
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Combined intravenous ganciclovir and foscarnet for children with recurrent cytomegalovirus retinitis.
    Walton RC; Whitcup SM; Mueller BU; Lewis LL; Pizzo PA; Nussenblatt RB
    Ophthalmology; 1995 Dec; 102(12):1865-70. PubMed ID: 9098289
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Treatment of cytomegalovirus retinitis in AIDS patients using intravitreal injections of highly concentrated ganciclovir.
    Baudouin C; Chassain C; Caujolle C; Gastaud P
    Ophthalmologica; 1996; 210(6):329-35. PubMed ID: 8887389
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Controversies in the treatment of cytomegalovirus retinitis: foscarnet versus ganciclovir.
    Jabs DA
    Infect Agents Dis; 1995 Sep; 4(3):131-42. PubMed ID: 8548191
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ganciclovir implants (Vitrasert).
    Treat Rev; 1996 Apr; (no 21):10. PubMed ID: 11363393
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cytomegalovirus retinitis successfully treated with ganciclovir implant in a patient with blood ganciclovir resistance and ocular ganciclovir sensitivity.
    Bakshi NK; Fahle GA; Sereti I; Wiley H; Nussenblatt RB; Sen HN
    Eye (Lond); 2012 May; 26(5):759-60. PubMed ID: 22322999
    [No Abstract]   [Full Text] [Related]  

  • 49. Potential complication associated with removal of ganciclovir implants.
    Boyer DS; Posalski J
    Am J Ophthalmol; 1999 Mar; 127(3):349-50. PubMed ID: 10088752
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Emergence of drug-resistant cytomegalovirus retinitis in the contralateral eyes of patients with AIDS treated with ganciclovir.
    Imai Y; Shum C; Martin DF; Kuppermann BD; Drew WL; Margolis TP
    J Infect Dis; 2004 Feb; 189(4):611-5. PubMed ID: 14767813
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Treatment of cytomegalovirus retinitis in AIDS patients with intravitreal ganciclovir.
    Ausayakhun S; Yuvaves P; Ngamtiphakom S; Prasitsilp J
    J Med Assoc Thai; 2005 Nov; 88 Suppl 9():S15-20. PubMed ID: 16681046
    [TBL] [Abstract][Full Text] [Related]  

  • 52. High dose oral ganciclovir treatment for cytomegalovirus retinitis.
    Lalezari JP; Friedberg DN; Bissett J; Giordano MF; Hardy WD; Drew WL; Hubbard LD; Buhles WC; Stempien MJ; Georgiou P; Jung DT; Robinson CA;
    J Clin Virol; 2002 Feb; 24(1-2):67-77. PubMed ID: 11744430
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The changing treatment options for CMV retinitis.
    Gilden D
    GMHC Treat Issues; 1995; 9(7/8):1-8. PubMed ID: 11362648
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Survival differences associated with treatment of cytomegalovirus retinitis in Maryland patients with AIDS, 1987-1994.
    Wutoh AK; Hidalgo J; Rhee W; Bareta J; Steidl S
    Am J Health Syst Pharm; 1999 Jul; 56(13):1314-8. PubMed ID: 10683128
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pathological findings in eyes with the ganciclovir implant.
    Srivastava SK; Martin DF; Mellow SD; Parks DJ; Dastgheib K; Chan CC
    Ophthalmology; 2005 May; 112(5):780-6. PubMed ID: 15878057
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Treatment of cytomegalovirus retinitis with a sustained-release ganciclovir implant. The Ganciclovir Implant Study Group.
    Musch DC; Martin DF; Gordon JF; Davis MD; Kuppermann BD
    N Engl J Med; 1997 Jul; 337(2):83-90. PubMed ID: 9211677
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Phase I study of combination therapy with intravenous cidofovir and oral ganciclovir for cytomegalovirus retinitis in patients with AIDS.
    Jacobson MA; Wilson S; Stanley H; Holtzer C; Cherrington J; Safrin S
    Clin Infect Dis; 1999 Mar; 28(3):528-33. PubMed ID: 10194072
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Once-weekly intraocular injections of ganciclovir for maintenance therapy of cytomegalovirus retinitis: clinical and ocular outcome.
    Hodge WG; Lalonde RG; Sampalis J; Deschênes J
    J Infect Dis; 1996 Aug; 174(2):393-6. PubMed ID: 8699072
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Ganciclovir intraocular implant.
    Morley MG; Duker JS; Reichel E
    Ophthalmology; 1996 Oct; 103(10):1517. PubMed ID: 8874416
    [No Abstract]   [Full Text] [Related]  

  • 60. Intraocular therapy for cytomegalovirus retinitis.
    Palestine AG
    J Int Assoc Physicians AIDS Care; 1996 May; 2(5):25-8. PubMed ID: 11363527
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.